๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Novel Metabolic Drugs and Blood Pressure: Implications for the Treatment of Obese Hypertensive Patients?

โœ Scribed by Engeli, Stefan; Jordan, Jens

Book ID
125376014
Publisher
Springer
Year
2013
Tongue
English
Weight
124 KB
Volume
15
Category
Article
ISSN
1522-6417

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Effect of dexfenfluramine treatment on b
Effect of dexfenfluramine treatment on body weight, blood pressure and noradrenergic activity in obese hypertensive patients
โœ J. Kolanowski; L. T. Younis; R. Vanbutsele; J. -M. Detry ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› Springer ๐ŸŒ English โš– 839 KB

The effect of dexfenfluramine (dF) on body weight, blood pressure and noradrenergic activity were studied in 30 obese hypertensive patients randomly divided into two groups and treated for 3 months either with dF (30 mg daily; 16 subjects) or placebo (Pl; 14 subjects). 11 patients from the dF group